Literature DB >> 7947089

Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor alpha/epidermal growth factor receptor mitogenic pathway.

I A Mórocz1, D Schmitter, B Lauber, R A Stahel.   

Abstract

Malignant cells frequently acquire a certain independency of exogenous growth factors via the coexpression of epidermal growth factor receptor (EGFR) and epidermal growth factor (EGF)-related molecules. In the present study we investigate a possible involvement of EGF-related molecules in the growth of human lung mesothelioma. Four well-characterised cell lines are analysed for their responsiveness to exogenous EGF and transforming growth factor alpha (TGF-alpha) as well as for coexpression of EGFR and EGF/TGF-alpha. Both growth factors are able to stimulate DNA synthesis in three cell lines, although the degree of responsiveness is very variable, but neither EGF nor TGF-alpha has an effect on the cell line ZL34. In contrast, no heterogeneity is observed in the expression of EGFR, which is similarly high in all cell lines. Analysis of cell supernatants reveals that, whereas no EGF is detected, TGF-alpha is released by two cell lines. Furthermore, these two cell lines, ZL5 and ZL34, are shown to express the membrane anchored precursor pro-TGF-alpha. Thus, coexpression of EGFR and TGF-alpha is observed on two mesothelioma cell lines. The potential autocrine mitogenic role of TGF-alpha in these two cell lines was tested using neutralising antibodies against TGF-alpha and EGFR. In ZL5 cells DNA synthesis was not affected by the presence of neutralising antibodies, indicating that an external autocrine mitogenic pathway is not active in these cells. In ZL34 cells, however, the potential autocrine loop could be disrupted, as DNA synthesis was significantly reduced in the presence of neutralising antibodies. This result gives strong evidence for an autocrine role of TGF-alpha in the growth of the mesothelioma cell line ZL34.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947089      PMCID: PMC2033553          DOI: 10.1038/bjc.1994.410

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

Review 1.  Transforming growth factor-alpha and its role in neoplastic progression.

Authors:  D C Lee; N C Luetteke; L A Petch
Journal:  Cancer Treat Res       Date:  1992

Review 2.  Growth factors: regulation of normal and neoplastic growth.

Authors:  L Pusztai; C E Lewis; J Lorenzen; J O McGee
Journal:  J Pathol       Date:  1993-02       Impact factor: 7.996

3.  Autocrine secretion and malignant transformation of cells.

Authors:  M B Sporn; G J Todaro
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

4.  Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.

Authors:  V Rusch; J Baselga; C Cordon-Cardo; J Orazem; M Zaman; S Hoda; J McIntosh; J Kurie; E Dmitrovsky
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

5.  Growth control in a human colon carcinoma cell line mediated by cell-associated transforming growth factor-alpha (TGF alpha).

Authors:  M A Zorbas; L C Yeoman
Journal:  Exp Cell Res       Date:  1993-05       Impact factor: 3.905

6.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody.

Authors:  T Kawamoto; J D Sato; A Le; J Polikoff; G H Sato; J Mendelsohn
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Role of transforming growth factor alpha (TGF-alpha) in the transformation of ras-transfected rat intestinal epithelial cells.

Authors:  J Filmus; W Shi; T Spencer
Journal:  Oncogene       Date:  1993-04       Impact factor: 9.867

8.  Bidirectional modulation of TNF-alpha production by alveolar macrophages in asbestos-induced pulmonary fibrosis.

Authors:  S Ouellet; H Yang; R A Aubin; R G Hawley; G F Wenckebach; I Lemaire
Journal:  J Leukoc Biol       Date:  1993-03       Impact factor: 4.962

9.  Tumorigenic conversion of human mesothelial cells as a consequence of platelet-derived growth factor-A chain overexpression.

Authors:  A Van der Meeren; M B Seddon; C A Betsholtz; J F Lechner; B I Gerwin
Journal:  Am J Respir Cell Mol Biol       Date:  1993-02       Impact factor: 6.914

10.  Interferon-induced enhancement of transforming growth factor-alpha expression in a human breast cancer cell line.

Authors:  A W Hamburger; G Pinnamaneni
Journal:  Proc Soc Exp Biol Med       Date:  1993-01
View more
  3 in total

1.  Increased epidermal growth factor-receptor protein in a human mesothelial cell line in response to long asbestos fibers.

Authors:  J C Pache; Y M Janssen; E S Walsh; T R Quinlan; C L Zanella; R B Low; D J Taatjes; B T Mossman
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

2.  Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma.

Authors:  Aki Murakami; Chiharu Tabata; Rie Tabata; Hisaya Okuwa; Takashi Nakano
Journal:  Oncol Lett       Date:  2011-12-23       Impact factor: 2.967

3.  Orthotopic pleural mesothelioma in mice: SPECT/CT and MR imaging with HER1- and HER2-targeted radiolabeled antibodies.

Authors:  Tapan K Nayak; Marcelino Bernardo; Diane E Milenic; Peter L Choyke; Martin W Brechbiel
Journal:  Radiology       Date:  2013-01-17       Impact factor: 11.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.